SEC Form 4 filed by Executive VP Clark Moore
4 - PEDEVCO CORP (0001141197) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Hardwick Mark K
4 - FIRST MERCHANTS CORP (0000712534) (Issuer)
- SEC Form 4 filed by Director Harmon Cyrus
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Tariq Musa sold $255,893 worth of shares (1,951 units at $131.16), decreasing direct ownership by 15% to 11,048 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- SEC Form 4 filed by Director Butitta Cynthia M
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Potter Myrtle S sold $204,085 worth of shares (1,556 units at $131.16), decreasing direct ownership by 7% to 20,971 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- SEC Form 4 filed by Director Garland J. Scott
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Mignone Roberto converted options into 528 shares, increasing direct ownership by 6% to 9,482 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- SEC Form 4 filed by Director Hrustanovic Gorjan
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form 4 filed by Director Clark Ian T
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- SEC Form 4 filed by Director Larson Yi
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Ballal Rahul D. converted options into 2,816 shares, increasing direct ownership by 23% to 15,230 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)
- SEC Form 4 filed by Director Horning Sandra
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Capello Jeffrey D converted options into 2,816 shares, increasing direct ownership by 35% to 10,865 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)
- Chief Executive Officer Ciaffoni Joseph converted options into 1,266,903 shares and covered exercise/tax liability with 612,549 shares, increasing direct ownership by 481% to 790,330 units (SEC Form 4) to cover taxes
4 - Indivior Pharmaceuticals, Inc. (0001625297) (Issuer)
- Director Foster-Cheek Kaye I converted options into 2,816 shares, increasing direct ownership by 38% to 10,284 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)
- SEC Form 4 filed by Director Raman Prakash
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)
- Director Fouse Jacqualyn A converted options into 2,816 shares, increasing direct ownership by 2% to 154,156 units (SEC Form 4)
4 - AGIOS PHARMACEUTICALS, INC. (0001439222) (Issuer)
- SEC Form 4 filed by Director Rappaport Andrew
4 - Olema Pharmaceuticals, Inc. (0001750284) (Issuer)